Retatrutide Raw Powder (CAS 2381089 - 83 - 2)

Basic Information

Matching Image Description 1: Retatrutide Raw Powder Appearance

Quality Specifications

1. Purity: The purity detected by HPLC is usually ≥ 98%, and some high-grade products can reach up to 99.9%. The total impurity content is less than 2.0%, and a single impurity does not exceed 1.0%, which meets strict pharmaceutical raw material requirements.
2. Key Component Control: The sodium content ranges from 5.0% - 12.0%, and the peptide content is not less than 80.0%. The moisture content tested by the Karl Fischer method is ≤ 10.0%, ensuring the stability of the powder during storage.
3. Compliance: The production process complies with GMP-level standards. Manufacturers can provide COA certificates to confirm the product's compliance and quality reliability, which lays a foundation for its application in scientific research and pharmaceutical pilot production.

Matching Image Description 2: Quality Testing Process

Storage and Packaging

1. Packaging: Common specifications include 10mg/vial, 100mg/vial, 1g/bottle, etc., and can also be customized according to customer needs. The powder is usually stored in sealed glass vials after lyophilization, and 10 vials are often packed in one box for easy transportation and storage. For bulk orders, it can be packed in vacuum-sealed aluminum foil bags and placed in paper drums.
2. Storage Conditions: Short-term storage can be done at 2 - 8°C in a cool, dry, and light-proof environment. For long-term storage, it is recommended to store it in a freezer at -20°C or below. Repeated freezing and thawing should be avoided to prevent the loss of peptide activity.
3. Transportation: Professional cold chain transportation is adopted, with real-time temperature monitoring to ensure that the transportation temperature meets the storage requirements and avoid quality changes caused by temperature fluctuations.

Matching Image Description 3: Packaging and Storage Scenarios

Mechanism of Action and Application Fields

1. Core Mechanism: It is a triple hormone receptor agonist that exerts its effects by simultaneously activating the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic peptide receptor (GIPR), and glucagon receptor (GCGR). This unique mechanism enables it to regulate blood sugar and promote weight loss from multiple pathways.
2. Main Applications:
   • Weight Loss Research: It has shown excellent performance in clinical trials. For overweight adults, the weight loss effect can exceed 17.5%, and the maximum weight loss can reach 24.2%, making it a key research object in the field of obesity treatment.
   • Type 2 Diabetes Research: It can effectively reduce blood sugar and help control glycated hemoglobin levels, providing a new research direction for the development of drugs for type 2 diabetes.
   • Other Potential Research Directions: Preclinical studies have shown that it may have antidepressant, anxiolytic, and neuroprotective effects, and may also be used in research on cognitive enhancement and chronic pain treatment, but...